Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Ovarian Cycle01:27

Ovarian Cycle

1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

514
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
514
Oogenesis01:22

Oogenesis

1.5K
Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
1.5K
Folliculogenesis01:20

Folliculogenesis

779
Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
779
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

391
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
391
Proliferative Phase01:20

Proliferative Phase

479
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
479

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Delayed childbearing and its impact.

Reproductive biomedicine online·2026
Same author

Re-evaluating endometrial injury for IVF: was a promising approach abandoned prematurely? A critical review.

Reproductive biomedicine online·2026
Same author

Mathematical modelling of premature haematopoietic ageing in dyskeratosis congenita.

Scientific reports·2026
Same author

Molecular and endocrine differences in early miscarriage associated with KIR polymorphisms in European ancestry women.

Reproductive biomedicine online·2026
Same author

Live birth rates after natural cycle versus artificial cycle in women receiving donated oocytes and the impact of female age.

Human reproduction (Oxford, England)·2026
Same author

Comparison of one-step and conventional warming in sibling donor oocytes: a proof-of-concept study.

Reproductive biomedicine online·2026

相关实验视频

Updated: Jul 4, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.0K

孕激素主导的卵巢刺激

Juan Giles1, Fabio Cruz1, Juan A Garcia-Velasco2

  • 1IVI-RMA Valencia, Plaza de la Policía Local 3, Valencia, Spain; IVI Foundation - IIS La Fe. Avenida Fernando Abril Martorell, Torre, Valencia.

Current opinion in obstetrics & gynecology
|January 31, 2024
PubMed
概括
此摘要是机器生成的。

孕激素是在体外受精 (IVF) 中卵巢刺激 (OS) 的有效垂体抑制剂. 它们提供了一种安全,经济高效的替代品,用于释放性腺激素 (GnRH) 的类似物,特别是用于冷解的胚胎移植.

更多相关视频

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

4.0K
Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

4.6K

相关实验视频

Last Updated: Jul 4, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.0K
OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

4.0K
Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

4.6K

科学领域:

  • 生殖内分泌学 生殖内分泌学
  • 在体外受精过程中受精.

背景情况:

  • 孕激素抑制排卵,使其能够在卵巢刺激 (OS) 协议中使用.
  • 它们可以替代性腺激素释放激素 (GnRH) 类似物,用于防止体外受精 (IVF) 过程中黄素化激素的激增.

研究的目的:

  • 审查OS中的孕激素协议,比较它们的疗效,安全性和成本效益与GnRH类似物.
  • 分析孕激素对卵细胞,胚胎和IVF生殖结果的影响.

主要方法:

  • 在OS协议中对孕激素使用的现有文献的审查.
  • 在各种患者群体和生殖程序中对孕激素协议与GnRH模拟协议进行比较分析.

主要成果:

  • 孕激素显示出作为淋巴激素辅助剂的有效性,改善卵巢反应,生殖结果和安全性.
  • 孕激素提供方便的口服,并且比GnRH类似物更具成本效益.

结论:

  • 孕激素是一种可行且有效的选择,用于OS中垂体抑制,在安全性和成本方面具有优势.
  • 虽然有效,但孕激素的使用需要胚胎冷保存,因为胚胎发育和子宫内膜受容性之间的潜在异步,使它们成为冷解胚胎移植周期的理想选择.